PDCD1 and cancer: Molecules that suppress immune responses against self or excessive immune responses, such as CTLA‐4 and programmed cell death 1 (PD‐1), are called immune checkpoint molecules, and malignant neoplasms utilize immune suppression mechanisms mediated by these molecules to escape the host's immune surveillance mechanisms.4